Xiao, D., Weng, J., Zhang, L., Xing, C., Wei, Y., Chen, Y. (2025). Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China. PLoS ONE. https://doi.org/10.1371/journal.pone.0310497